1. Home
  2. ANNX vs BH Comparison

ANNX vs BH Comparison

Compare ANNX & BH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.32

Market Cap

812.7M

Sector

Health Care

ML Signal

HOLD

Logo Biglari Holdings Inc. Class B

BH

Biglari Holdings Inc. Class B

HOLD

Current Price

$275.89

Market Cap

971.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANNX
BH
Founded
2011
1934
Country
United States
United States
Employees
N/A
2359
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
812.7M
971.1M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ANNX
BH
Price
$5.32
$275.89
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$16.50
N/A
AVG Volume (30 Days)
1.9M
57.1K
Earning Date
05-11-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$16,320.74
N/A
P/E Ratio
N/A
$597.67
Revenue Growth
N/A
N/A
52 Week Low
$1.85
$234.92
52 Week High
$7.18
$483.60

Technical Indicators

Market Signals
Indicator
ANNX
BH
Relative Strength Index (RSI) 44.52 44.11
Support Level $5.28 $269.96
Resistance Level $5.61 $321.70
Average True Range (ATR) 0.30 16.05
MACD -0.03 1.18
Stochastic Oscillator 40.34 55.14

Price Performance

Historical Comparison
ANNX
BH

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About BH Biglari Holdings Inc. Class B

Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, and Oil and Gas Operations. Its restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The company also reports segment information for Maxim. The majority of revenue is derived from the Restaurant Operations Segment.

Share on Social Networks: